Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alzheimer Disease With Psychosis”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT00034762
What this trial is testing

Efficacy and Safety of Risperidone Compared With Placebo in the Treatment of Psychotic Symptoms in Patients With Alzheimer's Disease

Who this might be right for
DementiaAlzheimer DiseaseMental Disorders
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 473
Early research (Phase 1)Not Yet RecruitingNCT06644573
What this trial is testing

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

Who this might be right for
Chronic InsomniaSleep DeprivationREM Behavior Disorder+34 more
Nyree Penn 100
Large-scale testing (Phase 3)Ended earlyNCT00287742
What this trial is testing

The Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease

Who this might be right for
Alzheimer's DiseaseDementia
Janssen Pharmaceutical K.K. 33
Large-scale testing (Phase 3)Looking for participantsNCT05511363
What this trial is testing

Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 410
Large-scale testing (Phase 3)UnknownNCT00190021
What this trial is testing

Donepezil Treatment of Psychotic Symptoms in Dementia Patients

Who this might be right for
Dementia of Alzheimer Type
Beersheva Mental Health Center 80
Large-scale testing (Phase 3)Ended earlyNCT00160147
What this trial is testing

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

Who this might be right for
Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type
Solvay Pharmaceuticals 60
Testing effectiveness (Phase 2)Looking for participantsNCT06540833
What this trial is testing

Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease

Who this might be right for
Psychotic DisordersAlzheimer Disease
Intra-Cellular Therapies, Inc. 370
Large-scale testing (Phase 3)Study completedNCT01922258
What this trial is testing

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Who this might be right for
Agitation Associated WithAlzheimer's DiseaseAlzheimer's Type+2 more
Otsuka Pharmaceutical Development & Commercialization, Inc. 270
Large-scale testing (Phase 3)Looking for participantsNCT06159673
What this trial is testing

ACP-204 in Adults With Alzheimer's Disease Psychosis

Who this might be right for
Alzheimer's Disease Psychosis
ACADIA Pharmaceuticals Inc. 1,074
Not applicableStudy completedNCT04113967
What this trial is testing

Efficacy of a Biodanza Program in People With Alzheimer's Disease.

Who this might be right for
Alzheimer Dementia (AD)Mental DisorderMood Disorders+1 more
Universidad de Almeria 40
Large-scale testing (Phase 3)Looking for participantsNCT06947941
What this trial is testing

Evaluate Safety and Efficacy of KarXT + KarX-EC as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-5)

Who this might be right for
Alzheimer DiseasePsychosis
Bristol-Myers Squibb 325
Not applicableEnrolling By InvitationNCT07314190
What this trial is testing

Retrospective Observational Study of Blood-based Biomarkers in the Diagnosis and Monitoring of Patients With a Neurodegenerative Disease or Mental Disorder

Who this might be right for
Alzheimer DiseaseDementia With Lewy Bodies (DLB)Frontotemporal Dementia (FTD)+4 more
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 1,799
Large-scale testing (Phase 3)Looking for participantsNCT06126224
What this trial is testing

Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

Who this might be right for
Psychosis Associated With Alzheimer's Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 500
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07459660
What this trial is testing

An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis

Who this might be right for
Psychosis Associated With Alzheimer's Disease
MapLight Therapeutics 210
Large-scale testing (Phase 3)Study completedNCT00041678
What this trial is testing

Study of Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of the Alzheimer's Type

Who this might be right for
Alzheimer Disease
Otsuka Pharmaceutical Development & Commercialization, Inc.
Early research (Phase 1)Not Yet RecruitingNCT06980207
What this trial is testing

A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Who this might be right for
Hallucinations and Delusions Associated With Alzheimer's Disease PsychosisHallucinations and Delusions Associated With Parkinson Disease PsychosisNegative Symptoms of Schizophrenia
Luye Pharma Group Ltd. 40
Testing effectiveness (Phase 2)Ended earlyNCT03044249
What this trial is testing

MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Who this might be right for
PsychosisDementiaAggression+2 more
Mediti Pharma Inc. 81
Early research (Phase 1)Looking for participantsNCT07230652
What this trial is testing

MAD Study to Evaluate the Safety and Tolerability of LY03020

Who this might be right for
SchizophreniaAlzheimer's Disease Psychosis
Luye Pharma Group Ltd. 40
Large-scale testing (Phase 3)Study completedNCT01438060
What this trial is testing

Aripiprazole in the Treatment of Patients With Psychosis Associated With Dementia of Alzheimer's Type

Who this might be right for
Dementia, Alzheimer Type
Otsuka Pharmaceutical Development & Commercialization, Inc. 232
Large-scale testing (Phase 3)Looking for participantsNCT06585787
What this trial is testing

Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

Who this might be right for
Alzheimer Disease
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 406
Next Page